Oncology Brothers: Practice-Changing Cancer Discussions
The Oncology Brothers Podcast, led by Drs. Rahul and Rohit Gosain, is dedicated to bridging the gap between academic cancer centers and community oncology in the ever-evolving field of hematology & oncology. With a mission to disseminate crucial information to the medical community, this oncology podcast is not for medical advice but rather serves as a beacon for physicians, nurses, trainees, and advanced practice providers (APPs) involved in the care of cancer patients. Drs. Rahul and Rohit Gosain, both esteemed oncologists, bring a wealth of experience and expertise from their general community practice to these discussions. Through short and engaging interviews with world-renowned researchers, clinicians, hematologists, and oncologists, they present practice-changing data in a concise, bite-sized format. Get the latest FDA approvals news, oncology conference highlights, and treatment algorithms in 25 minutes or less. Conversations center around common cancers you see in your clinic like breast cancer, prostate cancer, kidney cancer, bladder cancer, lung cancer, and GI cancers. With new indications and approvals, we talk about how to incorporate this data in your day to day clinical practice. Each episode includes visual presentations so you can follow along within the podcast players and on YouTube @oncbrothers. These visual tools and algorithms will provide an outline on what is covered in each episode. Immediately apply the latest insights and advancements in your daily practice, ensuring the delivery of optimal cancer care to patients within your local communities. If you want to navigate the complexities of your hematology & oncology practice and stay current, the Oncology Brothers Podcast offers invaluable insights and practical takeaways to enhance your professional journey and improve patient outcomes. For more information, please visit: www.oncbrothers.com, and connect with us on Twitter/X/Instagram/TikTok: @oncbrothers, or email us at info@oncbrothers.com
Listen on:
Episodes
Wednesday Dec 21, 2022
Wednesday Dec 21, 2022
Discussing Triple Negative Breast Cancer (TNBC) from the SABCS 2022 - Practice changing studies with Dr. Maryam Lustberg, Director of Breast Cancer Center, Chief of Breast Medical Oncology, Associate Professor of Internal Medicine at Yale Cancer Center - Yale School of Medicine.
CME Information link: https://integrityce.com/courses/clinical-updates-from-san-antonio-triple-negative-breast-cancer-neoadjuvant-adjuvant-immunotherapy/
Website: http://www.oncbrothers.com/
Twitter: https://twitter.com/oncbrothers
Contact us at info@oncbrothers.com
Tuesday Dec 20, 2022
Tuesday Dec 20, 2022
Discussing practice-changing studies from the American Society of Hematology (ASH) 2022 with Dr. Aaron Goodman "Papa Heme", Associate Professor of Medicine at UC San Diego Health - San Diego Hospital.
Website: http://www.oncbrothers.com/
Twitter: https://twitter.com/oncbrothers
Contact us at info@oncbrothers.com
Monday Dec 19, 2022
Monday Dec 19, 2022
Discussing HER 2 neu Positive (HER2+) from SABCS 2022 - Practice changing studies with Dr. Erika Hamilton, Director of Breast & Gynecologic Cancer Research, Sarah Cannon Research Institute.
CME Information link: https://integrityce.com/courses/clinical-updates-from-san-antonio-her2-and-her2-low-breast-cancer/
Website: http://www.oncbrothers.com/
Twitter: https://twitter.com/oncbrothers
Contact us at info@oncbrothers.com
Thursday Dec 15, 2022
Thursday Dec 15, 2022
Discussing new SERDs in Hormone Receptor Positive (HR+) from SABCS 2022 - Practice changing studies with Dr. Stephanie Graff, Director of Breast Oncology, Associate Professor of Medicine at Lifespan Cancer Institute, Brown University; Medical Advisor, Dr. Susan Love Foundation
CME information and credit available at: https://integrityce.com/courses/clinical-updates-from-san-antonio-her2-advanced-breast-cancer-heavily-pretreated-patients/
Website: http://www.oncbrothers.com/
Twitter: https://twitter.com/oncbrothers
Contact us at info@oncbrothers.com
Tuesday Dec 13, 2022
Tuesday Dec 13, 2022
Discussing Hormone Receptor Positive (HR+) Highlights from SABCS 2022 on usage of CDK4/6 inhibitors - Practice changing studies with Dr. Sara Tolaney, Chief - Division of Breast Oncology at Dana-Farber and Associate Professor at Harvard Medical School.
CME information and credit available at: https://integrityce.com/courses/clinical-updates-from-san-antonio-hr-her2-breast-cancer-cdk-4-6-inhibitors/
Website: http://www.oncbrothers.com/
Twitter: https://twitter.com/oncbrothers
Contact us at info@oncbrothers.com
Friday Nov 25, 2022
Friday Nov 25, 2022
Discussing the management using the algorithm of Upper Gastrointestinal (GI) Cancer (including esophageal, GEJ, gastric) - with Dr. Rutika Mehta, Assistant Professor of Oncology at Moffitt Cancer Center.
Website: http://www.oncbrothers.com/
Twitter: https://twitter.com/oncbrothers
Contact us at info@oncbrothers.com
Thursday Nov 17, 2022
Thursday Nov 17, 2022
Discussing the management using the algorithm of Triple Negative Breast Cancer (TNBC) - with Dr. Shipra Gandhi, Assistant Professor of Oncology at Roswell Park Comprehensive Cancer Center.
Website: http://www.oncbrothers.com/
Twitter: https://twitter.com/oncbrothers
Contact us at info@oncbrothers.com
Monday Nov 07, 2022
Monday Nov 07, 2022
Discussing the management using the algorithm of HER 2 Neu Positive Breast Cancer - with Dr. Erika Hamilton, Director of Breast & Gynecologic Cancer Research, Sarah Cannon Research Institute.
Monday Nov 07, 2022
Monday Nov 07, 2022
Discussing the management using the algorithm of Hormone Receptor Positive Breast Cancer - with Dr. Stephanie Graff, Director of Breast Oncology, Associate Professor of Medicine at Lifespan Cancer Institute, Brown University; Medical Advisor, Dr. Susan Love Foundation.
Monday Nov 07, 2022
Monday Nov 07, 2022
Discussing practice-changing Melanoma studies presented at the European Society of Medical Oncology 2022 with Dr. Sapna Patel, Director of Uveal Melanoma, Program Director of Melanoma Fellowship, Associate Professor at the University of Texas - MD Anderson Cancer Center.